Still Exhausted on HRT? Digestive Health and Nutrient Needs in the Next Stage of Treatment

Hormone replacement therapy is an evidence-backed and effective treatment for many perimenopausal symptoms, including fatigue, sleep disruption, hot flushes, and mood disruption. For many women, it's transformative.

But for a significant number, fatigue, brain fog, and low mood persist even after starting HRT, or improve initially and then plateau. A clinically important and under-discussed reason for this is that oestrogen-containing HRT interacts with several of the same nutrient pathways that were already under pressure during perimenopause and it adds new digestive and metabolic factors of its own.

This is not an argument against HRT. It's an argument for understanding that HRT addresses the hormonal dimension of perimenopausal fatigue, while nutrient depletion and digestive function represent parallel mechanisms that need their own attention.

The way oestrogen-containing formulations affect nutrient status runs through three distinct pathways: effects on liver metabolism (how nutrients are processed), effects on gut absorption, and effects on renal excretion (how much is lost in urine).

This is most thoroughly documented for oral oestrogen, which passes through the liver via "first-pass metabolism" before reaching circulation. Transdermal HRT (patches, gels) bypasses this first-pass step and may have a smaller impact on some of these pathways; though the evidence base specifically for transdermal formulations is thinner than for oral oestrogen and oral contraceptives, so this shouldn't be assumed without individual context.

The depletion associations below are drawn from pharmacological review literature (most directly a well-known 2019 clinical review in US Pharmacist on drug-induced nutrient depletions ) and from research on oral contraceptives, which share the relevant oestrogen-metabolism pathways with HRT even though the doses and contexts differ

Why HRT Adds a New Layer - Three Pathways

There's a digestive mechanism specific to HRT that doesn't come up in most discussions of nutrition during this stage, and it's worth understanding because it connects everything in Part 1 directly to hormone therapy.

After oestrogen (that is whether produced naturally or taken as HRT) is processed by the liver, it's released into the gut via bile in an inactive, "conjugated" form. From there, certain gut bacteria produce an enzyme called beta-glucuronidase, which can reactivate that oestrogen and allow it to be reabsorbed back into circulation through the gut wall; a cycle known as enterohepatic recirculation. This collection of gut bacteria capable of metabolising oestrogen has been termed the estrobolome, a concept first proposed in 2011 and since explored in a number of reviews on gut microbiome–hormone interactions.

In practice, this means the composition and diversity of your gut microbiome can influence how much of your circulating oestrogen (including oral HRT), which travels through the gut and liver before reaching the bloodstream and gets recycled versus excreted. A gut environment disrupted by low microbial diversity, the cortisol-driven permeability changes described in Part 1, or antibiotic use can shift this balance in either direction. This is an active area of research rather than a settled, fully mapped mechanism, but it's a clear, evidence-based reason why the gut health measures in Part 1 (supporting microbiome diversity, managing stress, limiting alcohol) remain just as relevant once you start HRT, and arguably more so if you're on an oral formulation.

Your Gut and Your Oestrogen: The Estrobolome

What HRT Depletes and Why

A woman on HRT who remains persistently fatigued, mentally flat, or emotionally brittle may not be under-dosed on hormones. She may be B vitamin deficient — and the HRT may be a contributing factor.

B Vitamins (B2, B6, B12, Folate)

Oestrogen-containing medications ( both oral contraceptives and HRT) are well documented to interact with the metabolism of B vitamins, particularly B6, B12, and folate. The pharmacological literature confirms that oestrogen can interfere with B6 metabolism, reduce folate absorption, and increase folate excretion, and that it can contribute to additional shortfalls in B2, B12, vitamin C, vitamin E, magnesium, selenium, and zinc. Worth noting: the same literature observes that low-dose oral contraceptives appear to partly self-correct for B6 specifically in some women (that these effects vary by dose, formulation, and individual, rather than being uniform).

For B6 specifically: the depletion matters because B6 is the cofactor required to synthesise both serotonin and GABA. Low B6 in the context of HRT may help explain why some women find their mood, sleep, and anxiety remain poor despite adequate hormone levels. For folate and B12: both are required for the methylation cycle, and their combined depletion raises homocysteine — a marker associated with fatigue, cardiovascular risk, and cognitive decline. The interaction compounds: B6 deficiency impairs the body's ability to use folate and B12, even when those levels look adequate on a blood test.

Magnesium

Oestrogen in HRT increases the uptake of magnesium into bone and soft tissue, which can lower the amount circulating in blood. This is consistent with the same liver- and tissue-distribution mechanisms that the broader nutrient-depletion literature describes for oestrogen-containing medications.

Magnesium is essential for sleep quality, muscle relaxation, energy metabolism, and HPA axis regulation - precisely the systems HRT is meant to support. If magnesium is being pulled down by the HRT itself, a subset of the symptoms it's meant to address can persist or return: poor sleep, night sweats, anxiety, fatigue, and muscle tension. This creates a situation where HRT appears to be working only partially, without an obvious clinical explanation, unless magnesium status is specifically checked.

Magnesium glycinate is generally the most bioavailable and well-tolerated supplemental form, and is the one most often recommended in clinical nutrition contexts for perimenopausal and menopausal women.

Zinc

Oestrogen-containing medications have been linked to changes in zinc absorption and excretion that can reduce its availability. This compounds the zinc deficiency risk that already exists from the hormonal changes of perimenopause itself, and from the stomach-acid-dependent absorption issues discussed in Part 1.

Given zinc's role in supporting oestrogen receptor function, thyroid metabolism, and neurotransmitter production, its depletion by HRT is something of a biochemical irony: the treatment intended to restore hormonal signalling may, in some women, be undermining the cellular machinery that receives and responds to that signal.

Vitamins C and E

Both vitamin C and vitamin E may be reduced by oestrogen-containing medications. Vitamin C plays roles in collagen synthesis, immune function, cortisol metabolism, and recycling other antioxidants. Vitamin E is a fat-soluble antioxidant involved in immune regulation and cardiovascular protection. The evidence base for these particular depletions is real but less robust than for B vitamins and magnesium, and is drawn mostly from research on oral contraceptives rather than HRT specifically. Women using transdermal oestrogen shouldn't assume the same degree of depletion applies to them.

CoQ10 and Statins

A specific concern applies to women on HRT who are also prescribed statins. This combination is clinically common, since cardiovascular risk rises during perimenopause. Statins are one of the most well-documented drug-related depleters of CoQ10: they inhibit the mevalonate pathway, which is needed for both CoQ10 synthesis and cholesterol production. Women in this position face a double depletion of CoQ10 (from age and declining oestrogen on one side, and statin use on the other) often without routine clinical awareness or monitoring of this overlap.

The Thyroid Mimicker Still Applies

Everything said in Part 1 about thyroid function applies just as much on HRT. Perimenopausal and postmenopausal women carry an elevated risk of thyroid dysfunction, particularly Hashimoto's thyroiditis. Its symptoms — exhaustion, weight gain, cold intolerance, hair thinning, brain fog, low mood — overlap heavily with both perimenopausal symptoms and with the nutrient-depletion picture above. A standard TSH test alone can miss both an underactive thyroid and Hashimoto's; a full panel (TSH, Free T3, Free T4, TPO antibodies) is needed to rule it out properly, especially before attributing persistent fatigue to nutrient depletion or hormone dosing alone.

What to Test on HRT

The same baseline panel from Part 1 applies, repeated at 3–6 month intervals after starting HRT, with particular attention to the nutrients most consistently linked to oestrogen-related changes:

- B12 and folate (both, plus active B12 if results are borderline)
- Red cell magnesium
- Zinc
- Serum ferritin
- Vitamin D (25-OH)
- Full thyroid panel: TSH, Free T3, Free T4, TPO antibodies
- HbA1c and fasting glucose
- Hormone markers as clinically indicated: oestradiol, progesterone, testosterone + SHBG, DHEA-S

If you're on an oral formulation and also taking a statin, it's worth specifically discussing CoQ10 status with your prescriber, since this combination isn't routinely flagged.

Practical Foundations for Women on HRT

Most of the foundations from Part 1 carry over directly — bioavailable supplement forms, food sources, gut support, blood sugar stability — and are worth re-reading if you skipped straight to this post. A few points are worth emphasising specifically for HRT:

Test before adjusting anything. Don't assume fatigue that persists on HRT means the dose is wrong. Rule out nutrient depletion and thyroid dysfunction first.

Discuss route of administration with your prescriber if depletion is a concern. Transdermal oestrogen (patches, gels) bypasses first-pass liver metabolism and may carry a smaller nutrient-depletion burden than oral oestrogen for some of these pathways, though this is a conversation for your GP or menopause specialist, not a reason to switch formulations unilaterally.

Support gut diversity deliberately, especially on oral HRT. Given the estrobolome mechanism above, the same measures from Part 1 (fermented foods, fibre diversity, limiting alcohol, managing stress) have a plausible added benefit for women on oral oestrogen specifically, beyond their general benefit for nutrient absorption.

Reassess periodically, not just once. Nutrient status on HRT isn't static, it's worth rechecking at the 3–6 month intervals noted above, particularly in the first year, as your body adjusts to treatment.

Key Takeaways

HRT addresses the hormonal dimension of perimenopausal fatigue effectively for many women, but it operates alongside, not instead of, the nutrient and digestive factors covered in Part 1. Oestrogen-containing HRT adds a further depletion layer of its own, particularly affecting B6, B12, folate, magnesium, and zinc, through effects on liver metabolism, gut absorption, and renal excretion. The gut microbiome adds another dimension specific to HRT: through the estrobolome, gut bacteria influence how much circulating oestrogen is recycled versus excreted, linking digestive health directly to how effectively HRT works.

Women who start HRT and find that fatigue, brain fog, or low mood persist may not be failing to respond to treatment. They may be experiencing nutrient depletion that's been compounded by it, and the same digestive groundwork from Part 1 remains the place to start untangling which is which.

Test, don't guess. Treat the root, not the symptom, and reassess as your treatment evolves.

This article is for informational purposes only and does not constitute medical advice. Any decisions regarding supplementation, testing, or adjusting hormone therapy should be made in consultation with a qualified clinician.

References

1. Pharmacist reference. Drug-Induced Nutrient Depletions: What Pharmacists Need to Know. US Pharmacist. 2019.
2. McArthur JO, Tang H, Petocz P, Samman S. Biological Variability and Impact of Oral Contraceptives on Vitamins B6, B12 and Folate Status in Women of Reproductive Age. Nutrients. 2013. doi:10.3390/nu5093634
3. Effect of Zinc Supplementation on Homocysteine, Vitamin B12 and Folate Concentrations in a Postmenopausal Population. J Trace Elem Med Biol. 2022. doi:10.1016/S0946-672X(22)00022-0
4. Plottel CS, Blaser MJ. Microbiome and Malignancy. Cell Host Microbe. 2011 (origin of the "estrobolome" concept).
5. Kwa M, Plottel CS, Blaser MJ, Adams S. The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer. J Natl Cancer Inst. 2016 (review of estrobolome mechanism and enterohepatic recirculation of oestrogen).
6. Tsai IC, Hsu CW, Chang CH, Tseng PT, Chang KV. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Front Pharmacol. 2022;13:883251. doi:10.3389/fphar.2022.883251
7. See also Part 1 references for shared mechanisms (mitochondrial function, gut acid decline, vitamin D activation, magnesium and B6 depletion pathways).

Follow us